Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 159 | 224 | 142 | 25,305 | 1,498 |
| Cost of Goods | 64 | 85 | 54 | 2,038 | 3,639 |
| Gross Profit | 95 | 139 | 88 | 23,267 | -2,141 |
| Operating Expenses | 26,403 | 24,187 | 28,551 | 27,658 | 28,495 |
| Operating Income | -26,244 | -23,963 | -28,409 | -4,353 | -29,997 |
| Other Income | 5,287 | -3,381 | -121 | 16,979 | -5,498 |
| Pre-tax Income | -20,957 | -27,344 | -28,530 | 12,626 | -35,495 |
| Income Tax | 1 | 10 | N/A | 324 | 49 |
| Net Income Continuous | -20,958 | -27,354 | -28,530 | 12,302 | -35,544 |
| Net Income | $-20,958 | $-27,354 | $-28,530 | $12,302 | $-35,544 |
| EPS Basic Total Ops | -0.45 | -0.57 | -0.60 | 0.25 | -0.75 |
| EPS Basic Continuous Ops | -0.44 | -0.58 | -0.60 | 0.25 | -0.76 |
| EPS Diluted Total Ops | -0.45 | -0.57 | -0.60 | 0.25 | -0.75 |
| EPS Diluted Continuous Ops | -0.44 | -0.58 | -0.60 | 0.25 | -0.76 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.54 | -0.60 | 0.27 | -0.75 |
| EBITDA(a) | $-26,088 | $-23,815 | $-28,271 | $-4,213 | $-29,846 |